You have 5 free searches left this month | for more free features.

Repurposed drugs

Showing 9976 - 10000 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Diabetes, Diabetes, Type 2 Trial in Russian Federation (biphasic insulin aspart)

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • biphasic insulin aspart
  • Arkhangelsk, Russian Federation
  • +10 more
Jan 5, 2017

Tocilizumab (RoActemra/Actemra) in Rheumatoid Arthritis

Completed
  • Rheumatoid Arthritis
  • Hospitalet de Llobregat, Barcelona, Spain
  • +15 more
Sep 8, 2016

Head Neck Cancer Trial in Miami (cisplatin, cytochlor, tetrahydrouridine)

Completed
  • Head and Neck Cancer
  • Miami, Florida
    University of Miami Sylvester Comprehensive Cancer Center
Dec 14, 2016

Pharmacodynamics of Ceftazidime in Pediatric ICU Patients

Unknown status
  • Sepsis
    • Chicago, Illinois
      Ann & Robert H Lurie Childjren's Hospital of Chicago
    Apr 25, 2017

    Low Lymphocyte Count in Patients With Type 2 Diabetes

    Completed
    • Diabetes Mellitus, Type 2
      • (no location specified)
      Nov 30, 2016

      Malaria, HIV Trial in Kampala (Dolutegravir 50mg od, Artemether-lumefantrine combination, Artesunate-amodiaquine)

      Completed
      • Malaria
      • HIV
      • Dolutegravir 50mg od
      • +2 more
      • Kampala, Uganda
        Infectious Diseases Institute
      Oct 4, 2016

      HIV Infection Trial in Philadelphia (Rifampicin 600 mg)

      Completed
      • HIV Infection
      • Rifampicin 600 mg
      • Philadelphia, Pennsylvania
        Drexel University College of Medicine
      Feb 28, 2017

      Nonsmall Cell Lung Cancer Trial in Beijing (Apatinib Mesylate Tablets, EGFR-TKIs (Erlotinib, Gefitinib and Osimertinib))

      Unknown status
      • Nonsmall Cell Lung Cancer
      • Apatinib Mesylate Tablets
      • EGFR-TKIs (Erlotinib, Gefitinib and Osimertinib)
      • Beijing, Beijing, China
        Peking University Third Hospital
      Feb 9, 2017

      Ventricular Tachycardia Trial in Portland (MRI guided VT ablation, Increased dose of amiodarone)

      Withdrawn
      • Ventricular Tachycardia
      • MRI guided VT ablation
      • Increased dose of amiodarone
      • Portland, Oregon
        Oregon Health & Science University
      May 9, 2017

      Tumors, Breast Trial in Worldwide (Lapatinib, Trastuzumab, Epirubicin)

      Withdrawn
      • Neoplasms, Breast
      • Graz, Austria
      • +5 more
      Jun 6, 2017

      Squamous Cell Carcinoma of the Head and Neck (SCCHN) Trial in Boston (Bevacizumab, erlotinib, Sulindac)

      Terminated
      • Squamous Cell Carcinoma of the Head and Neck (SCCHN)
      • Boston, Massachusetts
      • +1 more
      Mar 15, 2017

      Unresectable and Advanced Cholangiocarcinoma Trial in France (Sunitinib)

      Completed
      • Unresectable and Advanced Cholangiocarcinoma
      • Clichy, France
      • +5 more
      Jan 30, 2017

      Healthy Trial in Vienna (Timoptic® 0.5%, Timophtal sine® 0.5%, Genteal HA®)

      Terminated
      • Healthy
      • Timoptic® 0.5%
      • +4 more
      • Vienna, Austria
        Department of Clinical Pharmacology, Medical University of Vienn
      Dec 1, 2016

      Cervical Cancer Trial in Paris (cetuximab, cisplatin)

      Completed
      • Cervical Cancer
      • Paris, France
        Institut Curie Hopital
      Apr 4, 2017

      Opioid-Related Disorders Trial in Baltimore (Tramadol, Naloxone, Morphine)

      Completed
      • Opioid-Related Disorders
      • Baltimore, Maryland
        Johns Hopkins University (BPRU) Bayview Campus
      Jan 11, 2017

      Automatic Versus Evaluative Components of Cue Reactivity

      Completed
      • Drug Dependence
        • Baltimore, Maryland
          National Institute on Drug Abuse, Biomedical Research Center (BR
        Jun 30, 2017

        PET Imaging of Nicotinic Acetylcholine Receptors

        Completed
        • Healthy Volunteers
        • +2 more
          • Baltimore, Maryland
            National Institute on Drug Abuse, Biomedical Research Center (BR
          Jun 30, 2017

          Ovarian Function, Preservation of Ovarian Function Trial run by the NICHD (GnRH antagonist)

          Withdrawn
          • Ovarian Function
          • Preservation of Ovarian Function
          • GnRH antagonist
          • Bethesda, Maryland
            National Institutes of Health Clinical Center, 9000 Rockville Pi
          Jun 30, 2017

          Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, Smoldering Multiple Myeloma Trial in Cleveland (celecoxib,

          Completed
          • Monoclonal Gammopathy of Undetermined Significance
          • +2 more
          • Cleveland, Ohio
            Cleveland Clinic Foundation
          Dec 28, 2016

          NSCLC Trial in Boston (erlotinib, hydroxychloroquine)

          Terminated
          • Non-small Cell Lung Cancer
          • Boston, Massachusetts
            Massachusetts General Hospital
          Jan 27, 2017

          Marijuana Abuse Trial in New York (Nefazodone, Bupropion)

          Completed
          • Marijuana Abuse
          • New York, New York
            New York State Psychiatric Institute
          Jan 13, 2017

          Acute Lymphoblastic Leukemia Trial in Boston (Corticosteroid, Rapamycin)

          Completed
          • Acute Lymphoblastic Leukemia
          • Boston, Massachusetts
            Dana-Farber Cancer Institute
          Nov 21, 2016

          Hepatocellular Carcinoma Trial (TACE and Apatinib, TACE)

          Unknown status
          • Hepatocellular Carcinoma
          • TACE and Apatinib
          • TACE
          • (no location specified)
          Feb 23, 2017

          Diabetes, Type 2, Onychomycosis Trial in Vancouver (Laser Treatment YAG laser, Standard Treatment (control group) terbinafine

          Unknown status
          • Diabetes Mellitus, Type 2
          • Onychomycosis
          • Laser Treatment YAG laser
          • Standard Treatment (control group) terbinafine hydrochloride tablets
          • Vancouver, British Columbia, Canada
            Diamond Centre
          Feb 16, 2017

          Multiple Myeloma Trial in Boston (dexamethasone, lenalidomide, melphalan)

          Completed
          • Multiple Myeloma
          • Boston, Massachusetts
            Boston University Cancer Research Center
          Dec 28, 2016